Design, synthesis and biological evaluation of pyridazino[3,4,5-de]quinazolin-3(2H)-one as a new class of PARP-1 inhibitors.
Design, synthesis and biological evaluation of pyridazino[3,4,5-de]quinazolin-3(2H)-one as a new class of PARP-1 inhibitors.
复制标题
DOI:
10.1016/j.bmcl.2015.04.013
复制
发表时间:
2015-06
影响因子:
2.7
通讯作者:
Jie Wang;Hailiang Tan;Qi Sun;Z. Ge;Xin Wang;Yinye Wang;Runtao Li
中科院分区:
文献类型:
--
作者:
Jie Wang;Hailiang Tan;Qi Sun;Z. Ge;Xin Wang;Yinye Wang;Runtao Li
A series of pyridazino[3,4,5-de]quinazolin-3(2H)-one derivatives were designed and synthesized as PARP-1 inhibitors. Most of the synthesized compounds showed good inhibitory activities of PARP-1 and four of them achieved at the IC50values ranging from 0.0914 μM to 0.244 μM. Two compounds,1aand1b, were further tested for their neuroprotective effect in the PC12 cell model injured by H2O2and both of them exhibited excellent activities.